School Specialty Announces Fiscal Year 2016 Third Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
School Specialty Announces Fiscal Year 2016 Third Quarter Financial Results
  • Q3 Revenues increased $2.2 million or 0.7% vs. 2015 Q3
  • Q3 Gross Profit Margins of 37.0%, a decline of 70 basis points vs. 2015 Q3
  • Q3 SG&A expenses decreased $1.2 million or 1.8% vs. 2015 Q3
  • Q3 Operating Income of $47.0 million, up $0.1 million vs. 2015 Q3
  • Q3 Net Income of $42.9 million, a $4.0 million increase vs. 2015 Q3
  • Management updates Fiscal Year 2016 guidance

GREENVILLE, Wis., Nov. 01, 2016 (GLOBE NEWSWIRE) -- School Specialty, Inc. (OTCQB:SCOO) (“School Specialty”, “SSI” or “the Company”), a leading distributor of supplies, furniture and both curriculum and supplemental learning resources to the education, healthcare and other marketplaces, today announced financial results for its Fiscal 2016 third quarter ended September 24, 2016.

Joseph M. Yorio, President and Chief Executive Officer, stated, “Our fiscal third quarter represents the largest revenue quarter for our Company and I’m pleased that we remain on track to deliver a second consecutive year of growth.  While revenues were up over $2 million in the third quarter, we exited the quarter with a strong backlog of open orders in both our Furniture and Supplies product lines, which bodes well for the fourth quarter.  As the year-to-date results indicate, our performance in Furniture and Science continues to be strong.  Importantly though, we see progress towards our objective of achieving balanced growth as our broader Supplies category is showing modest growth and we are seeing strength in specialty areas such as Art, Early Learning and Special Needs.  Through the first nine months of the year, revenues and gross margins are up, operating expenses are down and we posted increases in operating income, net income and Adjusted EBITDA.  All in all, our year-to-date performance has been solid and we have a strong, dedicated team of employees that are “ Leading With Action ” and making it happen every day.  But, we are not satisfied and remain laser-focused on improving the value proposition to our customers and continuing to drive value for all constituents.”

Q3 Results (for the three months ended September 24, 2016 and September 26, 2015)

  • Revenues were $301.6 million, an increase of $2.2 million or 0.7%, as compared to revenues of $299.4 million.  Distribution segment revenues of $256.7 million decreased by $2.8 million or 1.1%, as compared to $259.5 million.  Supply category revenues grew $1.3 million or 1.1%, and the Furniture category was essentially flat for the comparable periods.  However, strong order trends within Furniture continued, and the Company exited the 2016 fiscal third quarter with a higher open order position and as such, expects growth in this category in the upcoming quarter.  The Company’s Agendas category declined consistent with expectations, given continued changes in the market for that product line.  Curriculum segment revenues of $44.9 million increased $5.0 million or 12.5%, as compared to revenues of $39.9 million in the comparable prior year quarter.   Growth in Curriculum was driven by continued strength in the Science category, which grew by approximately $5.3 million or 18.0%.  
  • Gross margin of 37.0% compared to 37.7% in the third quarter of 2015, a decline of 70 basis points (“bps”).  Distribution segment gross margin was 33.8% as compared to 34.8%, a decline of 100 bps that was primarily due to an increased number of Supplies orders being placed through strategic purchasing agreements, which typically price basic supplies at lower gross margins as a component of a broad product offering presented to customers.  A shift in product mix within the segment also contributed to the decrease in gross margin.  Curriculum segment gross margin was 55.5% as compared to 56.2%, a decline of 70 bps.  Decreased product development amortization year-over-year resulted in approximately 160 basis points of improvement in gross margin.  This decrease was offset by a shift in product mix, primarily driven by the growth in Science revenues for the comparable periods.  
  • Selling, General & Administrative (“SG&A”) expenses were $64.5 million as compared to $65.6 million, a decrease of $1.2 million or 1.8%.  This decline was primarily related to a $1.4 million decline in depreciation and amortization expense, as well as lower compensation and benefit costs compared to the prior year period.  These reductions to SG&A were partially offset by higher performance-based incentive compensation expense and higher marketing expense.  As a percent of revenue, SG&A decreased from 21.9% for the three months ended September 26, 2015 to 21.4% for the three months ended September 24, 2016.      
  • Operating income was $47.0 million as compared to $46.9 million in the comparable year-ago period.  Net income was $42.9 million as compared to net income of $38.9 million, an improvement of $4.0 million.  Net income for the third quarter of fiscal 2016 included a $9.1 million gain on the sale of the Company’s interest in an unconsolidated affiliate.  Tax expense for the quarter was $8.8 million as compared to $1.9 million in the prior year’s third quarter.   
  • Adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) was $52.9 million, as compared to Adjusted EBITDA of $54.3 million in the comparable 2015 period.

Nine-Month Results (for the nine months ended September 24, 2016 and September 26, 2015)

  • Revenues were $541.2 million, an increase of $9.2 million or 1.7%, as compared to revenues of $531.9 million.  Distribution segment revenues of $453.7 million were essentially flat (down 0.1%) as compared to the prior year nine-month period.  Revenues from the Company’s two largest product categories, Supplies and Furniture, increased by $2.8 million and $6.1 million, respectively, partially offsetting declines of $4.0 million and $4.2 million in the Agendas and AV Tech categories, respectively.  Curriculum segment revenues of $87.5 million increased $9.8 million or 12.6%, as compared to revenues of $77.7 million for the fiscal 2015 nine-month period.  Strong demand for the Company’s Next-Generation FOSS products helped drive a 17.6% increase in Science revenues, and the Reading category remained relatively unchanged (down 1.0%).  
  • Gross margin of 37.4% compared to 37.1% in the nine-month period of 2015 was an increase of approximately 30 basis points.  Distribution segment gross margin was 34.4% as compared to 35.2%, a decline of 80 bps.  This decline was directly related to a shift in product mix and an increase in the volume of orders placed through strategic purchasing and co-operative agreements.  Curriculum segment gross margin was 53.4% as compared to 48.1%, an increase of 530 bps.  The improvement in Curriculum segment gross margin was primarily related to lower product development amortization in the current year, which was partially off-set by a shift in mix towards the Science category.  
  • SG&A expenses were $165.0 million as compared to $170.9 million, a decrease of $6.0 million or 3.5%.  Expenses associated with cost reduction and process improvement initiatives were down $2.7 million in the first nine months of 2016, as compared to the comparable nine-month period in 2015. Depreciation and amortization expense in SG&A was down $3.2 million for the first nine months of 2016.  Overall compensation and benefits costs were $0.3 million higher year-over-year as a decrease in base compensation and benefit costs due to lower staffing levels was offset by incremental variable commission expense and performance-based compensation.  On a full-year basis, commission and performance-based compensation expenses are expected to be lower in 2016 as compared to the comparable 12-month period in 2015.  The Company also recognized a net foreign currency gain in the fiscal 2016 nine-month period of $0.7 million, compared to a net foreign currency loss of $0.8 million in the comparable 2015 period.  
  • Operating income was $37.0 million, as compared to operating income of $21.0 million in the comparable year-ago period, an improvement of $16.0 million.  Net income was $28.6 million, as compared to net income of $3.1 million, an improvement of $25.5 million.  
  • Adjusted EBITDA was $56.7 million, as compared to Adjusted EBITDA of $55.9 million, an improvement of $0.8 million or 1.4%. 

Yorio continued, “We have continued to invest in our business this year, and we have made substantial enhancements to our sales force structure, manufacturing and distribution capabilities, and in our systems.  These investments are enabling us to become more efficient, continue to improve our productivity and better serve our customers, while improving the scalability of our platform.  Curriculum, driven by Science, and Furniture continue to be strong growth drivers for our Company, but the strategies in place to grow our Supplies, Instructional Solutions and Reading categories are beginning to take hold.  Our balance sheet also continues to improve and our net total debt has declined by nearly $37 million as compared to the end of Q3 last year.  We believe we are positioned well to close out the year strong and look forward to reporting on our progress.”

Financial Outlook The Company today updated its guidance for FY16 (December 27, 2015 – December 31, 2016).  Total FY16 revenues are now anticipated to increase by approximately 2.1% - 2.3%.  Reported gross profit margins are anticipated to improve by 20 to 40 bps, driven by lower product development amortization costs. SG&A expenses are expected to decline by approximately 4.2% – 4.4%; SG&A expenses, excluding depreciation and amortization, are expected to be down approximately 2.5% year-over-year.  The Company’s updated FY16 Adjusted EBITDA guidance is approximately $49 - $51 million, representing year-over-year improvement of 8.9% - 13.3%.  The Company expects continued strong leveraged free cash flow of approximately $27.0 million to $29.0 million for FY16, an update from prior guidance. 

The Company’s Adjusted EBITDA and free cash flow for fiscal 2016, as indicated below, are non-GAAP measures.  A reconciliation of these non-GAAP measures to the nearest GAAP financial measure is presented in the following tables:

 
  Low End of Range   High End of Range
     
  Operating income $   23.1     $   24.6  
  Plus:      
    Depreciation and amortization     20.3         20.3  
    Restructuring-related costs     4.0         4.5  
    Stock-based compensation expense     1.6         1.6  
  Adjusted EBITDA $   49.0     $   51.0  
     
     
     
  Cash provided by operations $   34.0     $   37.0  
  Cash used in investing     (7.0 )       (8.0 )
  Leveraged free cash flow $   27.0     $   29.0  
 

Additional information on the Company’s outlook for 2016 can be found in the investor presentation on page 13, which will be published shortly under the Investor Relations section of the Company’s website.

School Specialty will be hosting a teleconference and webcast on November 3, 2016 at 9:00 a.m. ET to discuss its results and outlook.  Speaking from management will be Joseph M. Yorio, President and Chief Executive Officer and Ryan M. Bohr, Executive Vice President and Chief Financial Officer.

Conference Call Information

  • Toll-free number: 844-882-7832 / International number: 574-990-9706 / Conference ID: 9293017

For those who will be unable to participate, a teleconference replay will be available approximately five hours after the completion of the call and will last for one week (11/3/16 – 11/10/16).

Replay Information

  • Replay: 855-859-2056 / International replay: 404-537-3406 / Conference ID: 9293017

Interested parties can also participate in the live webcast or can access the archived call shortly thereafter, by visiting the School Specialty website in the Investor Relations section at http://investors.schoolspecialty.com . 

About School Specialty, Inc. School Specialty is a leading distributor of innovative and proprietary products, programs and services to the education marketplace.  The Company designs, develops, and provides educators with the latest and very best school supplies, furniture and both curriculum and supplemental learning resources.  Working in collaboration with educators, School Specialty reaches beyond the scope of textbooks to help teachers, guidance counselors and school administrators ensure that every student reaches his or her full potential.  Through its SSI Guardian subsidiary, the Company is also committed to school, healthcare and corporate workplace safety by offering the highest quality curriculum, training and safety and security products.  Through its recently launched SOAR Life Products brand, the Company offers thousands of products that sharpen cognitive skills and build physical and mental strength in fun and creative ways. From childhood through adulthood, they help individuals live life to the fullest – engaged, happy and well.  SOAR Life Products is a customized offering for hospitals, long-term care, therapeutic facilities, home care, surgery centers, day care centers, physician offices, and clinics.  For more information about School Specialty, visit www.schoolspecialty.com . 

Statement Concerning Forward-Looking Information Any statements made in this press release about School Specialty’s future financial condition, results of operations, expectations, plans, or prospects, including the information under the heading “Financial Outlook” constitute forward-looking statements.  Forward-looking statements also include those preceded or followed by the words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," “projects,” “should,” "targets" and/or similar expressions.  These forward-looking statements are based on School Specialty's current estimates and assumptions and, as such, involve uncertainty and risk. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those contemplated by the forward-looking statements because of a number of factors, including the risk factors described in Item 1A of School Specialty's Transition Report on Form 10-K for the 35-week transition period ended December 26, 2015, which risk factors are incorporated herein by reference.  Any forward-looking statement in this release speaks only as of the date on which it is made.  Except to the extent required under the federal securities laws, School Specialty does not intend to update or revise the forward-looking statements.

Non-GAAP Financial Information This press release includes references to Adjusted EBITDA and leveraged free cash flow, non-GAAP financial measures.  Adjusted EBITDA represents net income adjusted for: provision for (benefit from) income taxes; reorganization items, net; restructuring costs; restructuring-related costs included in SG&A; change in fair value of interest rate swap; loss on early extinguishment of debt; early termination fee; depreciation and amortization expense; amortization of development costs; net interest expense; and stock-based compensation.  Leveraged free cash flow represent Adjusted EBITDA adjusted for: capital expenditures; product development expenditures; proceeds from asset sales; unrealized foreign exchange gains and losses; restructuring and other expenditures; changes in working capital; cash interest and taxes. 

The Company considers Adjusted EBITDA a relevant supplemental measure of its financial performance and leveraged free cash flow a relevant supplemental measure of liquidity.  The Company believes these non-GAAP financial results provide useful supplemental information for investors regarding trends and performance of our ongoing operations and are useful for year-over-year comparisons of such results.  We also use these non-GAAP financial measures in making operational and financial decisions and in establishing operational goals.  The Company assesses its operating performance using both GAAP operating income and non-GAAP adjusted operating income in order to better isolate the impact of certain, material items that may not be comparable between periods. The Company believes that free cash flow provides a meaningful measure of its ability to generate cash and improve liquidity.  In addition, the Company believes it provides investors a useful basis for assessing the Company’s ability to fund both its operating activities and reinvestments into the business, as well as service its debt, including debt repayments.

In summary, we believe that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, helps investors to (i) evaluate our operating and financial performance and future prospects, (ii) compare financial results across accounting periods, (iii) better understand the long-term performance of our core business, and (iv) evaluate trends in our business, all consistent with how management evaluates such performance and movements.

Adjusted EBITDA does not represent, and should not be considered, an alternative to net income or operating income as determined by GAAP, and our calculation may not be comparable to similarly titled measures reported by other companies. Leveraged/Unleveraged Free Cash Flow does not represent, and should not be considered, an alternative to cash flow from operations.

 
SCHOOL SPECIALTY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, Except Per Share Amounts)
                               
          Three Months Ended September 24, 2016   Three Months Ended September 26, 2015   Nine Months Ended September 24, 2016   Nine Months Ended September 26, 2015   Twelve Months Ended September 24, 2016   Twelve Months Ended September 26, 2015
                               
Revenues   $   301,569     $   299,355     $   541,152     $   531,907     $   646,714     $   622,846  
Cost of revenues     190,011       186,606       338,530       334,753       408,905       395,270  
  Gross profit     111,558       112,749       202,622       197,154       237,809       227,576  
Selling, general and administrative expenses     64,454       65,629       164,977       170,933       218,981       221,595  
Facility exit costs and restructuring      93         230       642       2,518         1,241         5,550  
Impairment charges     -          -          -          2,713         -        2,713  
  Operating income (loss)     47,011       46,890       37,003       20,990       17,587       (2,282 )
Other expense:                        
  Interest expense     4,488       5,107         13,333         14,409         17,761         19,251  
  Early termination of long-term indebtedness     -          200         -          200         -          200  
  (Gain) on sale of unconsolidated affiliate       (9,090 )       -          (9,090 )       -          (9,090 )       -   
  Loss on early extinguishment of debt        -          877         -          877         -          877  
  Change in fair value of interest rate swap       (95 )       (50 )       (271 )       (41 )       (356 )       (61 )
Income (loss) before provision for income taxes     51,708       40,756       33,031       5,545       9,272       (22,549 )
Provision for (benefit from) income taxes     8,813       1,861       4,425       2,459       3,324       2,430  
  Net income (loss)   $   42,895     $   38,895     $   28,606     $   3,086     $   5,948     $   (24,979 )
                               
Weighted average shares outstanding:                        
  Basic       1,000         1,000         1,000         1,000         1,000         1,000  
  Diluted        1,000         1,000         1,000         1,000         1,000         1,000  
                               
Net income (loss) per Share:                        
  Basic   $   42.90     $   38.90     $   28.61     $   3.09     $   5.95     $   (24.98 )
  Diluted   $   42.90     $   38.90     $   28.61     $   3.09     $   5.95     $   (24.98 )
                               
                               
          Three Months Ended September 24, 2016   Three Months Ended September 26, 2015   Nine Months Ended September 24, 2016   Nine Months Ended September 26, 2015   Twelve Months Ended September 24, 2016   Twelve Months Ended September 26, 2015
    Adjusted Earnings before interest, taxes, depreciation,                    
      amortization, bankruptcy-related costs,   restructuring and impairment                  
      charges (Adjusted EBITDA) reconciliation:                        
      Net income (loss)   $   42,895     $   38,895     $   28,606     $   3,086     $   5,948     $   (24,979 )
      Provision for income taxes       8,813         1,861         4,425         2,459         3,324         2,430  
      Reorganization items, net       -          -          -          -          -          -   
      Restructuring costs       93         230         642         2,518         1,241         5,550  
      Restructuring-related costs incl in SG&A/COGS       564         332         2,143         4,808         3,743         5,508  
      Gain on sale of unconsolidated affiliate       (9,090 )       -          (9,090 )       -          (9,090 )       -   
      Change in fair value of interest rate swap       (95 )       (50 )       (271 )       (41 )       (356 )       (61 )
      Loss on early extinguishment of debt       -          877         -          877         -          877  
      Early termination fee       -          200         -          200         -          200  
      Depreciation and amortization expense       2,793         4,195         10,714         13,961         15,364         18,782  
      Amortization of development costs       1,954         2,403         5,029         10,027         6,492         12,010  
      Impairment charges       -          -          -          2,713         -          2,713  
      Net interest expense       4,488         5,107         13,333         14,409         17,761         19,251  
      Stock-based compensation       449         260         1,166         874         1,427         1,015  
      Adjusted EBITDA   $   52,864     $   54,310     $   56,697     $   55,891     $   45,854     $   43,296  

 

SCHOOL SPECIALTY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In Thousands)
                   
                   
              September 24, 2016   September 26, 2015
ASSETS          
Current assets:        
  Cash and cash equivalents   $   7,349     $   11,777  
  Accounts receivable, less allowance for doubtful accounts        
    of $1,605, $1,077, and $1,596, respectively       172,078       174,196  
  Inventories, net       84,848       89,003  
  Deferred catalog costs        2,563       1,598  
  Prepaid expenses and other current assets        13,238       14,920  
  Refundable income taxes       -          -   
    Total current assets        280,076       291,494  
Property, plant and equipment, net        28,722       28,881  
Goodwill       21,588       21,588  
Intangible assets, net       35,950       39,553  
Development costs and other       15,759       19,739  
Deferred taxes long-term     5         4  
Investment in unconsolidated affiliate     -        715  
    Total assets   $   382,100     $   401,974  
                   
LIABILITIES AND STOCKHOLDERS' EQUITY        
Current liabilities:        
  Current maturities - long-term debt   $   50,637     $   83,100  
  Accounts payable     43,970       33,814  
  Accrued compensation     13,266       12,947  
  Deferred revenue     3,547       4,070  
  Accrued income tax payable   3,471         1,030  
  Other accrued liabilities     18,801       18,200  
    Total current liabilities     133,692       153,161  
Long-term debt - less current maturities     136,686       143,497  
Other liabilities     95       1,087  
    Total liabilities     270,473       297,745  
                   
Stockholders' equity:        
  Preferred stock, $0.001 par value per share, 500,000        
    shares authorized; none outstanding       -          -   
  Common stock, $0.001 par value per share, 2,000,000 shares        
    authorized; 1,000,004 shares outstanding     1       1  
  Capital in excess of par value     120,405       118,980  
  Accumulated other comprehensive loss     (1,669 )     (1,687 )
  Retained earnings (accumulated deficit)     (7,110 )     (13,065 )
    Total stockholders' equity     111,627       104,229  
    Total liabilities and stockholders' equity   $   382,100     $   401,974  
                   

Company Contact Ryan M. Bohr Ryan.Bohr@SchoolSpecialty.com Tel: 920-882-5868 Investor and Media Relations Contact Glenn Wiener gwiener@GWCco.com Tel: 212-786-6011

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 99

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 138

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

CNX Resources Reveals Third Quarter Results and Upcoming Call

Updated Category News Views 36

CNX Resources Corporation Financial Update CNX Resources Corporation (NYSE: CNX) is gearing up to announce its financial outcomes for the third quarter of 2024. This announcement is scheduled for 6:45 a.m. Eastern Time on a Thursday morning toward the end of October. During this time, CNX will also share essential materials, including remarks prepared for the quarter,...

Continue Reading
MBZUAI Enhances Research Collaboration with École Polytechnique

Updated Category News Views 183

Strengthening Research Cooperation Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has officially expanded its strategic partnership with École Polytechnique, aiming for a more profound collaboration in artificial intelligence (AI) research. This new Collaborative Research Agreement is a significant step towards enhancing research capabilities in both...

Continue Reading
Projected Growth of Marine Collagen: Key Insights and Trends

Updated Category News Views 152

The Growing Marine Collagen Market The marine collagen market is set to experience significant growth in the coming years. As consumer awareness around health and beauty continues to rise, we see a shift in preference towards marine collagen, thanks to its impressive bioavailability and sustainable sourcing methods. Recent analyses reveal that this sector is predicted to...

Continue Reading
BioLife Solutions Prepares for Q1 2025 Financial Disclosure

Updated Category News Views 144

Exciting Financial Insights Awaiting from BioLife Solutions BioLife Solutions, Inc. (NASDAQ: BLFS) has announced that it will disclose its first quarter 2025 financial results, marking an important update for investors and stakeholders alike. This revelation is set to occur after the market closes, creating anticipation among those closely monitoring the company’s...

Continue Reading
FuboTV Achieves Record Subscriber Growth in North America

Updated Category News Views 174

FuboTV Reports Unprecedented Subscriber Growth FuboTV (NYSE: FUBO) has recently made headlines as it recorded the highest-ever growth in its North American subscriber base. This achievement highlights the company’s potential in the competitive streaming industry. The stock saw a notable increase on the day the company announced its earnings for the third quarter....

Continue Reading